Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expression

International Journal of Cancer

Volumn 122, Issue 10, 2008, Pages 2280-2285

  Lüking, Carolin ^a   Kronenberger, Konrad ^a   Frankenberger, Bernhard ^a   Nößner, Elfriede ^a   Röcken, Martin ^b   Mocikat, Ralph ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adoptive transfer; B cell lymphoma; IL 7 receptor; TCR chain repertoire; Trioma vaccination

Indexed keywords

CYTOKINE; INTERLEUKIN 7 RECEPTOR ALPHA; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER MODEL; CANCER SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; FEMALE; GENE EXPRESSION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 42149124271     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23393     Document Type: Article

References (36)

1. Melief CJM, Kast WM. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev 1995;146:167-77.
2. Kyewski B, Derbinski J. Self-representation in the thymus: an extended view. Nat Rev Immunol 2004;4:688-98.
3. Sotomayor EM, Borrello I, Tubb E, Rattis FM, Bien H, Lu Z, Fein S, Schoenberger S, Levitsky HI. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med 1999;5:780-7.
4. Bendle GM, Holler A, Pang L-K, Hsu S, Krampera M, Simpson E, Stauß HJ. Induction of unreponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes. Cancer Res 2004;64:8052-6.
5. Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. Adoptive T-cell therapy using antigen-specific CD8+ T-cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 2002;99:16168-73.
6. Kolb HJ, Mittermüller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-5.
7. Savoldo B, Heslop HE, Rooney CM. The use of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus induced lymphoma in transplant patients. Leuk Lymphoma 2000;39:455-64.
8. Dembic Z, Haas W, Weiss S, McCubrey J, Kiefer H, von Boehmer H, Steinmetz M. Transfer of specificity by murine α and β T cell receptor genes. Nature 1986;320:232-8.
9. Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 1999;163:507-13.
10. Willemsen RA, Weitjens MEM, Rotentalp C, Eshhar Z, Gratama JW, Chames P, Bolhuis RL. Grafting human lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther 2000;7:1369-77.
11. Roszkowski JJ, Lyons GE, Kast WM, Yee C, van Besien K, Nishimura MI. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of single T-cell receptor. Cancer Res 2005;65:1570-6.
12. Schumacher TNM. T-cell receptor gene therapy. Nat Rev Immunol 2002;2:512-9.
13. Sadelain M, Rivière I, Brentjens R. Targeting tumors with genetically enhanced T lymphocytes. Nat Rev Cancer 2002;3:35-45.
14. Egeter O, Mocikat R, Ghoreschi K, Dieckmann A, Röcken R. Eradication of disseminated lymphomas with CpG-DNA-activated Th1 cells from non-transgenic mice. Cancer Res 2000;60:1515-20.
15. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors and memory cells. Science 2000;290:92-7.
16. Plas DR, Rathmell JC, Thompson CB. Homeostatic control of lymphocyte survival: potential origins and implications. Nat Immunol 2002;3:515-21.
17. + T cells. J Exp Med 2002;195:1515-22.
18. Broome HE, Dargan CM, Krajewski S, Reed JC. Expression of Bcl-2. Bcl-x and Bax after T-cell activation and IL-2 withdrawal. J Immunol 1995;155:2311-7.
19. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat Immunol 2003;4:355-60.
20. Kim KJ, Kanellopoulos-Langvin C, Merwin RM, Sachs DH, Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 1979;122:549-54.
21. + T-cell-independent pathway for antitumor CTL induction. Blood 2005;106:338-44.
22. Laskov R, Scharf MD. Synthesis, assembly and secretion of γ globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of γ globulin subunits. J Exp Med 1970;131:515-41.
23. Mocikat R, Selmayr M, Thierfelder S, Lindhofer H. Trioma-based vaccination against B cell lymphoma confers long-lasting tumor immunity. Cancer Res 1997;57:2346-9.
24. Kronenberger K, Dieckmann A, Selmayr M, Strehl J, Wahl U, Lindhofer H, Kraal G, Mocikat R. Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells. Blood 2002;99:1327-31.
25. Strehl J, Selmayr M, Kremer J-P, Hültner L, Lindhofer H, Mocikat R. Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells. Int J Cancer 1999;83:113-20.
26. Becker C, Pohla H, Frankenberger B, Schüler T, Assenmacher M, Schendel DJ, Blankenstein T. Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay. Nat Med 2001;7:1159-62.
27. Harada M, Okamoto T, Omoto K, Tamada K, Takenoyama M, Hirashima C, Ito O, Kimura G, Nomoto K. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies. Immunology 1996;87:447-53.
28. Pannetier C, Cochet M, Drache S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993;90:4319-23.
29. Broeren CPM, Verjans GMGM, Van Eden W, Kusters JG, Lenstra JA, Logtenberg T. Conserved nucleotide sequences at the 5′ end of T cell receptor variable genes facilitate polymerase chain reaction amplification. Eur J Immunol 1991;21:569-75.
30. Li Y-S, Hayakawa K, Hardy RR. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med 1993;178:951-60.
31. Schüler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin-4-deficient mice. J Exp Med 1999;189:803-10.
32. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, Seegmüller I, Voigt H, Launois P, Levine AD, Wagner H, Heeg K, et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2001;2:1054-60.
33. Heath WR, Carbone FR, Bertolino P, Kelly J, Cose S, Miller JF. Expression of two T cell receptor alpha chains on the surface of normal murine T cells. Eur J Immunol 1995;25:1617-23.
34. Buentke E, Mathiot A, Tolaini M, Di Santo J, Zamoyska R, Seddon B. Do CD8 effector cells need IL-7R expression to become resting memory cells? Blood 2006;108:1949-56.
35. Robbins PF, Dudley ME, Wunderlich J, El Gamil M, Li YF, Zhou J, Huang J, Powell DJ, Rosenberg SA. Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol 2004;173:7125-30.
36. Powell DJ, Dudley ME, Hogan KA, Wunderlich JR, Rosenberg SA. Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion. J Immunol 2006;177:6527-39.